BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Barrea L, Vetrani C, Caprio M, Cataldi M, Ghoch ME, Elce A, Camajani E, Verde L, Savastano S, Colao A, Muscogiuri G. From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome). Curr Obes Rep 2022. [PMID: 35524067 DOI: 10.1007/s13679-022-00475-z] [Reference Citation Analysis]
2 Sweed D, El Shanshory MR, Elaskary EM, Hassan HA, Sweed E, Sweed E, Abdelsattar S, Abdelgawad A, Mosbeh A, Abdallah H, El-Mashad S, Ehsan N. Trichrome-positive intrahepatic cytoplasmic globules are potential histopathological clue for COVID-19-induced hepatitis: a case report. Egypt Liver J 2021;11:69. [PMID: 34777872 DOI: 10.1186/s43066-021-00140-5] [Reference Citation Analysis]
3 Hu K, Lin L, Liang Y, Shao X, Hu Z, Luo H, Lei M. COVID-19: risk factors for severe cases of the Delta variant. Aging (Albany NY) 2021;13:23459-70. [PMID: 34710058 DOI: 10.18632/aging.203655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Reference Citation Analysis]
5 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hutchison AL, Pillai A. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant 2021;26:339-45. [PMID: 33938470 DOI: 10.1097/MOT.0000000000000883] [Reference Citation Analysis]
8 Ihlow J, Seelhoff A, Corman VM, Gruber AD, Dökel S, Meinhardt J, Radbruch H, Späth-Schwalbe E, Elezkurtaj S, Horst D, Herbst H. COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis. BMC Infect Dis 2021;21:901. [PMID: 34479499 DOI: 10.1186/s12879-021-06605-7] [Reference Citation Analysis]
9 Okuhama A, Hotta M, Ishikane M, Kawashima A, Miyazato Y, Terada M, Yamada G, Kanda K, Inada M, Sato L, Sato M, Akiyama Y, Suzuki T, Nakamoto T, Nomoto H, Ide S, Nakamura K, Saito S, Kinoshita N, Yamamoto K, Morioka S, Ujiie M, Hayakawa K, Kustuna S, Shida Y, Tajima T, Teruya K, Funato Y, Yamamoto M, Izumi S, Hojo M, Sugiyama H, Ohmagari N. Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease. J Infect Chemother 2021:S1341-321X(21)00282-8. [PMID: 34756574 DOI: 10.1016/j.jiac.2021.10.013] [Reference Citation Analysis]
10 Peiter GC, de Souza CBT, de Oliveira LM, Pagliarin LG, dos Anjos VNF, da Silva FAF, de Melo FF, Teixeira KN. COVID-19 liver and gastroenterology findings: An in silico analysis of SARS-CoV-2 interactions with liver molecules. World J Hepatol 2022; 14(6): 1131-1141 [DOI: 10.4254/wjh.v14.i6.1131] [Reference Citation Analysis]
11 Spick M, Lewis HM, Frampas CF, Longman K, Costa C, Stewart A, Dunn-Walters D, Greener D, Evetts G, Wilde MJ, Sinclair E, Barran PE, Skene DJ, Bailey MJ. An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics. Sci Rep 2022;12:11867. [PMID: 35831456 DOI: 10.1038/s41598-022-16123-4] [Reference Citation Analysis]
12 Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. [DOI: 10.7759/cureus.23333] [Reference Citation Analysis]
13 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wong CKH, Au ICH, Cheng WY, Man KKC, Lau KTK, Mak LY, Lui SL, Chung MSH, Xiong X, Lau EHY, Cowling BJ. Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply. Aliment Pharmacol Ther 2022;55:1457-8. [PMID: 35538354 DOI: 10.1111/apt.16932] [Reference Citation Analysis]
15 Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep 2021;14:e244168. [PMID: 34446515 DOI: 10.1136/bcr-2021-244168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang MK, Yue HY, Cai J, Zhai YJ, Peng JH, Hui JF, Hou DY, Li WP, Yang JS. COVID-19 and the digestive system: A comprehensive review. World J Clin Cases 2021; 9(16): 3796-3813 [PMID: 34141737 DOI: 10.12998/wjcc.v9.i16.3796] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
17 Mashraqi A, Halawani H, Alelyani T, Mashraqi M, Makkawi M, Alasmari S, Shaikh A, Alshehri A. Prediction Model of Adverse Effects on Liver Functions of COVID-19 ICU Patients. J Healthc Eng 2022;2022:4584965. [PMID: 35480158 DOI: 10.1155/2022/4584965] [Reference Citation Analysis]
18 Lang C, Ritschl V, Augustin F, Lang G, Moser B, Taghavi S, Murakoezy G, Lambers C, Flick H, Koestenberger M, Brooks R, Muhr T, Knotzer J, Mydza D, Kaufmann M, Staudinger T, Zauner C, Krenn C, Schaden E, Bacher A, Rössler B, Faybik P, Tschernko E, Anwar M, Markstaller K, Höfer D, Stamm T, Jaksch P, Hoetzenecker K. Clinical relevance of lung transplantation for COVID-19 ARDS: a nationwide study. Eur Respir J 2022:2102404. [PMID: 35301249 DOI: 10.1183/13993003.02404-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tokarczyk U, Kaliszewski K, Kopszak A, Nowak Ł, Sutkowska-stępień K, Sroczyński M, Sępek M, Dudek A, Diakowska D, Trocha M, Gajecki D, Gawryś J, Matys T, Maciejiczek J, Kozub V, Szalast R, Madziarski M, Zubkiewicz-zarębska A, Letachowicz K, Kiliś-pstrusińska K, Matera-witkiewicz A, Pomorski M, Protasiewicz M, Sokołowski J, Adamik B, Kujawa K, Doroszko A, Madziarska K, Jankowska EA. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value. JCM 2022;11:4490. [DOI: 10.3390/jcm11154490] [Reference Citation Analysis]
20 Thiebaud PC, Hermand C, Sobotka J, Raynal PA. Acute icteric hepatitis as the first isolated symptom of COVID-19. BMJ Case Rep 2021;14:e242853. [PMID: 34088694 DOI: 10.1136/bcr-2021-242853] [Reference Citation Analysis]
21 Bütikofer S, Lenggenhager D, Wendel Garcia PD, Maggio EM, Haberecker M, Reiner CS, Brüllmann G, Buehler PK, Gubler C, Müllhaupt B, Jüngst C, Morell B. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Liver Int 2021. [PMID: 34018314 DOI: 10.1111/liv.14971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chen Y, Xu Y, Zhang K, Shen L, Deng M. Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target. Front Cell Infect Microbiol 2022;12:922511. [DOI: 10.3389/fcimb.2022.922511] [Reference Citation Analysis]
23 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
24 Sica R, Pennoni S, Penta L, Di Cara G, Verrotti A. New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report. Int J Environ Res Public Health 2021;18:6961. [PMID: 34209719 DOI: 10.3390/ijerph18136961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. CIMB 2022;44:1294-315. [DOI: 10.3390/cimb44030087] [Reference Citation Analysis]
26 Rivera-Valdes JJ, Martínez-Lopez E. The growing need to monitor the liver function after SARS-CoV-2 infection in the Mexican population with obesity. Ann Hepatol 2022;:100698. [PMID: 35259496 DOI: 10.1016/j.aohep.2022.100698] [Reference Citation Analysis]
27 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Saleh KB, Hafiz A, Alsulaiman K, Aljuhani O, Alharbi S, Alharbi A, Vishwakarma R, Albekairy A, Alkathiri A, Alanazi F, Almujarri G, Alobathani S, Alharbi Y, Zowawi HM, Badreldin HA. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study. Am Heart J Plus 2021;7:100033. [PMID: 34308397 DOI: 10.1016/j.ahjo.2021.100033] [Reference Citation Analysis]
29 Voiosu A, Roman A, Pop R, Boeriu A, Popp C, Zurac S, Voiosu T, Dobru D, Mateescu B. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience. Rom J Intern Med 2021. [PMID: 34253002 DOI: 10.2478/rjim-2021-0027] [Reference Citation Analysis]
30 Yoo HW, Jin HY, Yon DK, Effenberger M, Shin YH, Kim SY, Yang JM, Kim MS, Koyanagi A, Jacob L, Smith L, Yoo IK, Shin JI, Lee SW. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. J Korean Med Sci 2021;36:e291. [PMID: 34697932 DOI: 10.3346/jkms.2021.36.e291] [Reference Citation Analysis]
31 Huang J, Zhang Z, Hao C, Qiu Y, Tan R, Liu J, Wang X, Yang W, Qu H. Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor. Front Pharmacol 2022;13:804189. [DOI: 10.3389/fphar.2022.804189] [Reference Citation Analysis]
32 Sica R, Pennoni S, Penta L, Riccioni S, Di Cara G, Verrotti A. Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications. World J Gastroenterol 2021; 27(40): 7000-7004 [PMID: 34790020 DOI: 10.3748/wjg.v27.i40.7000] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Fassan M, Mescoli C, Sbaraglia M, Guzzardo V, Russo FP, Fabris R, Trevenzoli M, Pelizzaro F, Cattelan AM, Basso C, Navalesi P, Farinati F, Vettor R, Dei Tos AP. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens. Pathol Res Pract 2021;221:153451. [PMID: 33932720 DOI: 10.1016/j.prp.2021.153451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 López-Hernández Y, Monárrez-Espino J, Oostdam AH, Delgado JEC, Zhang L, Zheng J, Valdez JJO, Mandal R, González FLO, Moreno JCB, Trejo-Medinilla FM, López JA, Moreno JAE, Wishart DS. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci Rep 2021;11:14732. [PMID: 34282210 DOI: 10.1038/s41598-021-94171-y] [Reference Citation Analysis]
35 Ali AS, Ibrahim IM, Burzangi AS, Ghoneim RH, Aljohani HS, Alsamhan HA, Barakat J. Scoping insight on antiviral drugs against COVID-19. Arab J Chem 2021;14:103385. [PMID: 34909060 DOI: 10.1016/j.arabjc.2021.103385] [Reference Citation Analysis]
36 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Radzina M, Putrins DS, Micena A, Vanaga I, Kolesova O, Platkajis A, Viksna L. Post-COVID-19 Liver Injury: Comprehensive Imaging With Multiparametric Ultrasound. J Ultrasound Med 2021. [PMID: 34241914 DOI: 10.1002/jum.15778] [Reference Citation Analysis]
38 Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. [PMID: 34239378 DOI: 10.31486/toj.20.0086] [Reference Citation Analysis]
39 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
40 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Ito GNW, Rodrigues VAC, Hümmelgen J, Meschino GSPG, Abou-Rejaile GM, Brenny ID, de Castro Júnior CR, Artigas RC, Munhoz JPS, Cardoso GC, Picheth GF. COVID-19 pathophysiology and ultrasound imaging: A multiorgan review. J Clin Ultrasound 2022. [PMID: 35218034 DOI: 10.1002/jcu.23160] [Reference Citation Analysis]
43 Frater JL, Wang T, Lee Y. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. WJMA 2021;9:192-206. [DOI: 10.13105/wjma.v9.i2.192] [Reference Citation Analysis]
44 Sahin T, Simsek C, Balaban HY. Practical points that gastrointestinal fellows should know in management of COVID-19. World J Clin Cases 2022; 10(16): 5133-5145 [DOI: 10.12998/wjcc.v10.i16.5133] [Reference Citation Analysis]
45 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
46 Chen H, Chen Q. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD. Int J Biol Sci 2022;18:4756-67. [PMID: 35874945 DOI: 10.7150/ijbs.72461] [Reference Citation Analysis]
47 Bernstein D, Roth N, Kim A, Epstein M, Hirschwerk D, Kvasnovsky CL, Satapathy SK. Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease. World J Gastroenterol 2021; 27(42): 7350-7361 [PMID: 34876794 DOI: 10.3748/wjg.v27.i42.7350] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Boraschi P, Giugliano L, Mercogliano G, Donati F, Romano S, Neri E. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol 2021; 27(26): 4143-4159 [PMID: 34326615 DOI: 10.3748/wjg.v27.i26.4143] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
49 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021;13:522-32. [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Reference Citation Analysis]
50 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
51 Wanner N, Andrieux G, Badia-I-Mompel P, Edler C, Pfefferle S, Lindenmeyer MT, Schmidt-Lauber C, Czogalla J, Wong MN, Okabayashi Y, Braun F, Lütgehetmann M, Meister E, Lu S, Noriega MLM, Günther T, Grundhoff A, Fischer N, Bräuninger H, Lindner D, Westermann D, Haas F, Roedl K, Kluge S, Addo MM, Huber S, Lohse AW, Reiser J, Ondruschka B, Sperhake JP, Saez-Rodriguez J, Boerries M, Hayek SS, Aepfelbacher M, Scaturro P, Puelles VG, Huber TB. Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab 2022. [PMID: 35347318 DOI: 10.1038/s42255-022-00552-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
52 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF, Chui CSL, Chan EWY, Cheng WY, Cheng FWT, Yuen MF, Wong ICK. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol 2022:S0168-8278(22)02931-2. [PMID: 35817224 DOI: 10.1016/j.jhep.2022.06.032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Reference Citation Analysis]
55 Schwarz S, Lang C, Harlander M, Štupnik T, Slambrouck JV, Ceulemans L, Ius F, Gottlieb J, Kuhnert S, Hecker M, Aigner C, Kneidinger N, Verschuuren E, Smits J, Tschernko E, Schaden E, Faybik P, Markstaller K, Trauner M, Jaksch P, Hoetzenecker K. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.06.020] [Reference Citation Analysis]
56 Gama JFG, Cardoso LMDF, Lagrota-candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? WJCC 2022;10:2687-99. [DOI: 10.12998/wjcc.v10.i9.2687] [Reference Citation Analysis]
57 Teschke R, Méndez-Sánchez N, Eickhoff A. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method. Int J Mol Sci 2022;23:4828. [PMID: 35563242 DOI: 10.3390/ijms23094828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Hwaiz R, Merza M, Hamad B, HamaSalih S, Mohammed M, Hama H. Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol 2021;97:107701. [PMID: 33930704 DOI: 10.1016/j.intimp.2021.107701] [Reference Citation Analysis]
59 Chen C, Riyahi S, Prince M, Thomas C, RoyChoudury A, Browne WF, Sweeney E, Margolis DJ. Predictors of biliary intervention in patients hospitalized for COVID-19. Abdom Radiol (NY) 2022;47:1891-8. [PMID: 35234995 DOI: 10.1007/s00261-022-03461-0] [Reference Citation Analysis]
60 Moreira JLS, Barbosa SMS, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. [PMID: 34303828 DOI: 10.1016/j.clinre.2021.101752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ravichandran S, Manickam N, Kandasamy M. Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19. Med Drug Discov 2022;:100136. [PMID: 35721801 DOI: 10.1016/j.medidd.2022.100136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
63 Lax SF, Skok K, Zechner PM, Setaffy L, Kessler HH, Kaufmann N, Vander K, Cokić N, Maierhofer U, Bargfrieder U, Trauner M. [Systemic consequences and clinical aspects of SARS-CoV-2 infection]. Pathologe 2021;42:155-63. [PMID: 33575886 DOI: 10.1007/s00292-021-00913-0] [Reference Citation Analysis]
64 Delgado-Gonzalez P, Gonzalez-Villarreal CA, Roacho-Perez JA, Quiroz-Reyes AG, Islas JF, Delgado-Gallegos JL, Arellanos-Soto D, Galan-Huerta KA, Garza-Treviño EN. Inflammatory effect on the gastrointestinal system associated with COVID-19. World J Gastroenterol 2021; 27(26): 4160-4171 [PMID: 34326616 DOI: 10.3748/wjg.v27.i26.4160] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Pott-Junior H, Bittencourt NQP, Chacha SFG, Luporini RL, Cominetti MR, Anibal FF. Elevations in Liver Transaminases in COVID-19: (How) Are They Related? Front Med (Lausanne) 2021;8:705247. [PMID: 34336904 DOI: 10.3389/fmed.2021.705247] [Reference Citation Analysis]
66 Frater JL, Wang T, Lee YS. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. World J Meta-Anal 2021; 9(2): 193-207 [DOI: 10.13105/wjma.v9.i2.193] [Reference Citation Analysis]
67 Chen W, Liu H, Yang G, Wang W, Liu Q, Huang C, Zou Z, Liu Y, Zhuang G, Zhang L. Effect of Direct Bilirubin Level on Clinical Outcome and Prognoses in Severely/Critically Ill Patients With COVID-19. Front Med (Lausanne) 2022;9:843505. [PMID: 35419371 DOI: 10.3389/fmed.2022.843505] [Reference Citation Analysis]
68 Yuan WZ, Fu T. Liver Dysfunction in COVID-19: From Onset to Recovery. Semin Liver Dis 2022;42:151-8. [PMID: 35738256 DOI: 10.1055/s-0042-1745871] [Reference Citation Analysis]
69 Hofman P, Copin MC, Tauziede-Espariat A, Adle-Biassette H, Fortarezza F, Passeron T, Salmon I, Calabrese F. [Histopathological features due to the SARS-CoV-2]. Ann Pathol 2021;41:9-22. [PMID: 33446414 DOI: 10.1016/j.annpat.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Liemarto AK, Budiono BP, Chionardes MA, Oliviera I, Rahmasiwi A. Liver abscess with necrosis in post COVID-19: A case report. Ann Med Surg (Lond) 2021;72:103107. [PMID: 34840781 DOI: 10.1016/j.amsu.2021.103107] [Reference Citation Analysis]
71 Pegoraro F, Trapani S, Indolfi G. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children. Clin Res Hepatol Gastroenterol 2021;46:101818. [PMID: 34607068 DOI: 10.1016/j.clinre.2021.101818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
72 Çalhan T, Yivli E. Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5557] [Reference Citation Analysis]
73 Monroe I, Dale M, Schwabe M, Schenkel R, Schenarts PJ. The COVID-19 Patient in the Surgical Intensive Care Unit. Surg Clin North Am 2022;102:1-21. [PMID: 34800379 DOI: 10.1016/j.suc.2021.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 D’Ardes D, Boccatonda A, Cocco G, Fabiani S, Rossi I, Bucci M, Guagnano MT, Schiavone C, Cipollone F. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. World J Gastroenterol 2022; 28(11): 1102-1112 [DOI: 10.3748/wjg.v28.i11.1102] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Hartl L, Jachs M, Simbrunner B, Bauer DJM, Semmler G, Gompelmann D, Szekeres T, Quehenberger P, Trauner M, Mandorfer M, Scheiner B, Reiberger T. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. J Pers Med 2021;11:1264. [PMID: 34945736 DOI: 10.3390/jpm11121264] [Reference Citation Analysis]
76 Yousif WI. Reply to: "Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure". Dig Liver Dis 2021;53:1071-2. [PMID: 34257027 DOI: 10.1016/j.dld.2021.06.014] [Reference Citation Analysis]
77 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
78 Rosa L, Vincenzo M, Annalisa C, Federica I, Giordano S, Giada P, Marco P, Irene M, Beatrice M, Elisa F, Matteo C, Alessandra B, Luca V, Flora P, Nicola M, Marina B, Ludovica FA. Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity. Intern Emerg Med 2022. [PMID: 35754075 DOI: 10.1007/s11739-022-03000-1] [Reference Citation Analysis]
79 Jonigk D, Werlein C, Acker T, Aepfelbacher M, Amann KU, Baretton G, Barth P, Bohle RM, Büttner A, Büttner R, Dettmeyer R, Eichhorn P, Elezkurtaj S, Esposito I, Evert K, Evert M, Fend F, Gaßler N, Gattenlöhner S, Glatzel M, Göbel H, Gradhand E, Hansen T, Hartmann A, Heinemann A, Heppner FL, Hilsenbeck J, Horst D, Kamp JC, Mall G, Märkl B, Ondruschka B, Pablik J, Pfefferle S, Quaas A, Radbruch H, Röcken C, Rosenwald A, Roth W, Rudelius M, Schirmacher P, Slotta-Huspenina J, Smith K, Sommer L, Stock K, Ströbel P, Strobl S, Titze U, Weirich G, Weis J, Werner M, Wickenhauser C, Wiech T, Wild P, Welte T, von Stillfried S, Boor P. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Virchows Arch 2022. [PMID: 35364700 DOI: 10.1007/s00428-022-03319-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Bozada-Gutiérrez K, Trejo-Avila M, Chávez-Hernández F, Parraguirre-Martínez S, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Surgical treatment of acute cholecystitis in patients with confirmed COVID-19: Ten case reports and review of literature. World J Clin Cases 2022; 10(4): 1296-1310 [DOI: 10.12998/wjcc.v10.i4.1296] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut 2022:gutjnl-2021-326792. [PMID: 35701093 DOI: 10.1136/gutjnl-2021-326792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bonilla Gonzalez C, Hincapié Echeverría M, Plazas Pachón R, Mora Umaña P, Diaz Gómez BL, Gualdron Barreto N. Case Report: Fatal Acute Liver Failure With Giant Cell Transformation in a Pediatric Patient Associated With MIS-C. Front Pediatr 2022;9:780258. [DOI: 10.3389/fped.2021.780258] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pazgan-Simon M, Serafińska S, Kukla M, Kucharska M, Zuwała-Jagiełło J, Buczyńska I, Zielińska K, Simon K. Liver Injury in Patients with COVID-19 without Underlying Liver Disease. J Clin Med 2022;11:308. [PMID: 35054003 DOI: 10.3390/jcm11020308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Scarabelli A, Zilocchi M, Casiraghi E, Fasani P, Plensich GG, Esposito AA, Stellato E, Petrini A, Reese J, Robinson P, Valentini G, Carrafiello G. Abdominal Computed Tomography Imaging Findings in Hospitalized COVID-19 Patients: A Year-Long Experience and Associations Revealed by Explainable Artificial Intelligence. J Imaging 2021;7:258. [PMID: 34940725 DOI: 10.3390/jimaging7120258] [Reference Citation Analysis]
85 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
86 Pizuorno A, Fierro NA. Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic. Ann Hepatol 2021;22:100332. [PMID: 33631378 DOI: 10.1016/j.aohep.2021.100332] [Reference Citation Analysis]
87 Gama JFG, Cardoso LMDF, Lagrota-Candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? World J Clin Cases 2022; 10(9): 2685-2697 [DOI: 10.12998/wjcc.v10.i9.2685] [Reference Citation Analysis]
88 Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-33. [PMID: 34475732 DOI: 10.20524/aog.2021.0628] [Reference Citation Analysis]
89 Davies A, Åsenius F, Purcell F, Wu M, Al-rubaye A, Alrubaiy L. THE PATTERN AND LONG TERM FOLLOW UP OF COVID-19 RELATED ABNORMAL LIVER BLOOD TESTS. ijsr. [DOI: 10.36106/ijsr/6020892] [Reference Citation Analysis]
90 Qi X, Kong H, Ding W, Wu C, Ji N, Huang M, Li T, Wang X, Wen J, Wu W, Wu M, Huang C, Li Y, Liu Y, Tang J. Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation. Front Med (Lausanne) 2021;8:638194. [PMID: 34222271 DOI: 10.3389/fmed.2021.638194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Bethineedi LD, Suvvari TK. Post COVID-19 cholangiopathy - A deep dive. Dig Liver Dis 2021;53:1235-6. [PMID: 34412993 DOI: 10.1016/j.dld.2021.08.001] [Reference Citation Analysis]
92 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
94 Kaliszewski K, Diakowska D, Nowak Ł, Tokarczyk U, Sroczyński M, Sępek M, Dudek A, Sutkowska-stępień K, Kiliś-pstrusińska K, Matera-witkiewicz A, Pomorski M, Protasiewicz M, Sokołowski J, Adamik B, Kujawa K, Doroszko A, Madziarska K, Jankowska EA. Assessment of Gastrointestinal Symptoms and Dyspnea in Patients Hospitalized due to COVID-19: Contribution to Clinical Course and Mortality. JCM 2022;11:1821. [DOI: 10.3390/jcm11071821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Nayagam JS, Jeyaraj R, Mitchell T, Walder DP, Al-Agil M, Shek A, Barker R, Teo J, Maharaj R, Agarwal K, Vlachos S, Joshi D, McPhail MJ. Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection. J Infect 2021;82:e11-3. [PMID: 33826926 DOI: 10.1016/j.jinf.2021.03.029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, Bolomo A, Carlino Y, Bombassaro IZ, Wiltgen D, Castillo LT, Díaz K, Acuña J, Manero E, Prieto J, Carrera E, Díaz-Ferrer J, Debes JD. Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America. Can J Gastroenterol Hepatol 2021;2021:1622533. [PMID: 34621710 DOI: 10.1155/2021/1622533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Ballout RA, Kong H, Sampson M, Otvos JD, Cox AL, Agbor-Enoh S, Remaley AT. The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19. Biomedicines 2021;9:1090. [PMID: 34572275 DOI: 10.3390/biomedicines9091090] [Reference Citation Analysis]
99 Almas T, Ehtesham M, Khedro T, Haadi A, Nabeel AR, Hussain S, Alsufyani R, Al-Awaid AH, Sclair S, Mansoor E. The many faces of coronavirus disease 2019: COVID-19 and the liver. Ann Med Surg (Lond) 2021;64:102224. [PMID: 33747505 DOI: 10.1016/j.amsu.2021.102224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Vollenberg R, Tepasse PR, Fobker M, Hüsing-Kabar A. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients 2022;14:2007. [PMID: 35631143 DOI: 10.3390/nu14102007] [Reference Citation Analysis]